Lumexa Imaging Holdings, Inc. (LMRI) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $96.00K; Additional Paid in Capital, Common StockUSD $1.24B; Retained Earnings (Accumulated Deficit)USD $-626.60M; Stockholders' Equity Attributable to ParentUSD $615.06M.
- 2026-03-31: Common Stock, Value, IssuedUSD $96.00K; Additional Paid in Capital, Common StockUSD $1.23B; Retained Earnings (Accumulated Deficit)USD $-629.34M; Stockholders' Equity Attributable to ParentUSD $599.62M.
- 2025-12-31: Common Stock, Value, IssuedUSD $96.00K; Additional Paid in Capital, Common StockUSD $1.22B; Retained Earnings (Accumulated Deficit)USD $-631.06M; Stockholders' Equity Attributable to ParentUSD $586.12M.
- 2025-06-30: Common Stock, Value, IssuedUSD (m); Additional Paid in Capital, Common StockUSD (m); Retained Earnings (Accumulated Deficit)USD (m); Stockholders' Equity Attributable to ParentUSD $162.18M.
Lumexa Imaging Holdings, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|
| 2026-06-30 | $96.00K | $1.24B | $-626.60M | $615.06M | 3 month · $12.74M |
| 2026-03-31 | $96.00K | $1.23B | $-629.34M | $599.62M | 3 month · $12.27M |
| 2025-12-31 | $96.00K | $1.22B | $-631.06M | $586.12M | (m) |
| 2025-06-30 | (m) | (m) | (m) | $162.18M | 3 month · $8.35M |
| 2025-03-31 | (m) | (m) | (m) | $161.00M | 3 month · $6.37M |
| 2024-12-31 | (m) | (m) | (m) | $161.65M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B |